Dopamine and α-synuclein dysfunction in Smad3 null mice

BACKGROUND: Parkinson's disease (PD) is characterized by dopaminergic neurodegeneration in the substantia nigra (SN). Transforming growth factor-β1 (TGF-β1) levels increase in patients with PD, although the effects of this increment remain unclear. We have examined the mesostriatal system in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia-González, Silvia, Giráldez-Pérez, Rosa M, Cuartero, M Isabel, Casarejos, M José, Mena, M Ángeles, Wang, Xiao-Fan, Sánchez-Capelo, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219599/
https://www.ncbi.nlm.nih.gov/pubmed/21995845
http://dx.doi.org/10.1186/1750-1326-6-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219599/
https://www.ncbi.nlm.nih.gov/pubmed/21995845
http://dx.doi.org/10.1186/1750-1326-6-72

Ejemplares similares